J. Christopher Naftzger, General Counsel of Arbutus Biopharma ABUS, has filed 0 purchases and 1 sale on the open market. The latest trade was on 25/02/14.

JN

JN

J. Christopher Naftzger

General Counsel and CCO

Company

Arbutus Biopharma ABUS

First filing

23/07/12

Trades

6 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

25/02/14

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Arbutus BiopharmaABUS	Open-market sale10b5-1 plan	25/02/04	25/02/05	11,333 sh	$3.28	$37,172.24	−11.6%